Your browser doesn't support javascript.
loading
Design, synthesis, and biological activity of a novel series of 2,5-disubstituted furans/pyrroles as HIV-1 fusion inhibitors targeting gp41.
Jiang, Shibo; Tala, Srinivasa R; Lu, Hong; Zou, Peng; Avan, Ilker; Ibrahim, Tarek S; Abo-Dya, Nader E; Abdelmajeid, Abdelmotaal; Debnath, Asim K; Katritzky, Alan R.
Afiliação
  • Jiang S; Lindsley F. Kimball Research Institute, New York Blood Center, NY 10065, USA. sjiang@nybloodcenter.org
Bioorg Med Chem Lett ; 21(22): 6895-8, 2011 Nov 15.
Article em En | MEDLINE | ID: mdl-21978673
ABSTRACT
Based on molecular docking analysis of earlier results, we designed a series of 2,5-disubstituted furans/pyrroles (5a-h) as HIV-1 entry inhibitors. Compounds were synthesized by Suzuki-Miyaura cross coupling, followed by a Knoevenagel condensation or Wittig reaction. Four of these compounds were found to be effective in inhibiting HIV-1 infection, with the best compounds being 5f and 5h, which exhibited significant inhibition on HIV-1(IIIB) infection at micromolar levels with low cytotoxicity. These compounds are also effective in blocking HIV-1 mediated cell-cell fusion and the gp41 six-helix bundle formation, suggesting that they are also HIV-1 fusion inhibitors targeting gp41 and have potential to be developed as a new class of anti-HIV-1 agents.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirróis / Proteína gp41 do Envelope de HIV / HIV-1 / Inibidores da Fusão de HIV Limite: Humans Idioma: En Revista: Bioorg Med Chem Lett Assunto da revista: BIOQUIMICA / QUIMICA Ano de publicação: 2011 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirróis / Proteína gp41 do Envelope de HIV / HIV-1 / Inibidores da Fusão de HIV Limite: Humans Idioma: En Revista: Bioorg Med Chem Lett Assunto da revista: BIOQUIMICA / QUIMICA Ano de publicação: 2011 Tipo de documento: Article País de afiliação: Estados Unidos